Dandex

Neurometa Therapeutics ApS

CVR 44557703Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Aalborg ØstFounded 2 Jan 2024

Employees

2

CVR registry, May 2026

Gross profit

-17,5K

DKK, annual report 2025

Result

-18,6K

DKK, annual report 2025

Equity

-264,3K

DKK, annual report 2025

Who Is Behind It

Owner

Neurometa Therapeutics AB100% of capital and votes, since 29 Sep 2026

Directors

Preben Bruun-Nyzellsince 2 Jan 2024

Josephus Dirk Vestergaard Nielandsince 2 Jan 2024

Steinunn Sara Helgudóttirsince 2 Jan 2024

  • Equity was negative at 31 Dec 2025: -264,3K DKK. Dandex estimate, computed 19 Oct 2026.

Ownership

  • Neurometa Therapeutics AB

    100% of capital and votessince 29 Sep 2026

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Former owners (3)
  • Helgudottir Holding ApS

    CVR 4447366620% to under 25% of capital and votes2 Jan 2024 to 29 Sep 2026

  • AKGM Holding ApS

    CVR 4449133820% to under 25% of capital and votes2 Jan 2024 to 29 Sep 2026

  • J&P Pharma Holding AB

    33,3% to under 50% of capital and votes2 Jan 2024 to 29 Sep 2026

People

Current (3)

Founders (3)

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Former (1)

Network

Roles Over Time

2 Jan 2024 to 19 Oct 2026.

Former (1)

2 Jan 2024 to 19 Oct 2026.

Executive board (Direktion)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Financials

Annual report figures by year, DKK thousands
Metric20242025
Gross profit-32-17
Operating profit-285-19
Result for the year-286-19
Equity61-264
Total assets7757
Employees (average)Not reported0

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Annual Reports

  • Annual report 2025

    1 Jan 2025 to 31 Dec 2025, published 6 Jul 2026

    XHTML

  • Annual report 2024

    2 Jan 2024 to 31 Dec 2024, published 1 Jul 2025

    PDF

Changes

All changes

  1. Neurometa Therapeutics ApS has changed ownership. A new strategy and new needs can be expected.

    Signal, a Dandex estimate. Lapses 27 Jan 2027.

  2. Name change

    Neurometa Therapeutics ApS (CVR 44557703) har skiftet navn fra "Geysir Therapeutics ApS" til "Neurometa Therapeutics ApS" pr. 29. september 2026.

  3. Ownership change

    Neurometa Therapeutics ApS (CVR 44557703) har foretaget ejerskifte pr. 29. september 2026: 1 indtrådt.

  4. Address change

    Geysir Therapeutics ApS (CVR 44557703) har ændret adresse fra "Niels Jernes Vej 10 9220 Aalborg Øst" til "Kaolinvej 5 9220 Aalborg Øst" pr. 6. maj 2026.

  5. Ownership change

    Geysir Therapeutics ApS (CVR 44557703) har foretaget ejerskifte pr. 6. maj 2026: 3 indtrådt.

  6. Director change

    Geysir Therapeutics ApS (CVR 44557703) har foretaget direktørskifte pr. 2. januar 2024: 4 indtrådt.

Registration

Address
Kaolinvej 5
9220 Aalborg Øst
Aalborg Municipality
CVR record last changed
29 Sep 2026
Data read
19 Oct 2026

Production Units

1 registered in CVR.

  • Neurometa Therapeutics ApS

    P-number 1029996012Kaolinvej 5, 9220 Aalborg Øst

Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ask About Neurometa Therapeutics ApS With AI

Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.

Set Up MCPTry the Chat Demo